AMRN Stock Summary and Trading Ideas (Amarin PLC - American Depositary Shares | NASDAQ:AMRN)

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Amarin PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AMRN.

As of December 15, 2025, AMRN stock price declined to $14.14 with 113,987 million shares trading.

AMRN has a beta of 1.64, meaning it tends to be more sensitive to market movements. AMRN has a correlation of 0.21 to the broad based SPY ETF.

AMRN has a market cap of $294.01 million. This is considered a Small Cap stock.

Last quarter Amarin PLC - American Depositary Shares reported $50 million in Revenue and $.19 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.22.

In the last 3 years, AMRN traded as high as $44.60 and as low as $7.08.

The top ETF exchange traded funds that AMRN belongs to (by Net Assets): SPDW, GWX, IBBQ, BIB.

AMRN has outperformed the market in the last year with a return of +53.6%, while the SPY ETF gained +13.8%. However, in the most recent history, AMRN shares have underperformed the stock market with its stock returning -5.8% in the last 3 month period and -11.5% for the last 2 week period, while SPY has returned +3.8% and -0.4%, respectively.

AMRN support price is $13.87 and resistance is $14.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRN shares will trade within this expected range on the day.